Nov 25, 2022
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.77 to $0.08.
The split itself did not change the total investment value.
BiondVax Pharmaceuticals Ltd. (BVXV) trades on the NASDAQ Capital Market in the Biotechnology industry.
BiondVax Pharmaceuticals Ltd. company overviewThe latest split shown was on November 25, 2022. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records one reverse split, on November 25, 2022.
Already premium?